As summarized in the preceding sections, PD individuals who develop cognitive impairment are more likely to carry the APOE E4 genotype, more likely to have low CSF Aβ and high CSF and plasma NFL, and more likely to have positive amyloid PET scans. This evidence concerns the gene APOE and Parkinson disease.